**Current CDC FluSurv-NET data show laboratory-confirmed influenza-associated hospitalization rates at 0.1 per 100,000 population for Week 33 (ending August 22, 2026), with national activity remaining very low.** Influenza positive tests stood at just 0.8% in clinical laboratories, influenza-like illness visits at 1.1%, and emergency department diagnoses of flu at 0.1%. These figures align with typical late-summer patterns after the 2025-26 season peak (moderate severity, driven largely by A(H3N2) strains) concluded in spring. Week 34 rates (ending around August 29) are expected to stay near this baseline given stable low transmission, co-circulation of other respiratory viruses like rhinovirus, and no signs of early 2026-27 season onset. Preliminary FluSurv-NET and NHSN figures carry reporting lags and minor revisions that can shift the exact observed rate by small increments, creating genuine uncertainty around the precise 0.1 threshold. Market-implied odds reflect this tight balance between confirmed low-level persistence and the potential for negligible fluctuations driven by surveillance variability or isolated clusters. Updated FluView and RESP-NET releases in coming days will clarify the final observed value.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourTaux d'hospitalisation pour grippe Semaine 34, 2026 ?
Taux d'hospitalisation pour grippe Semaine 34, 2026 ?
0,1 50%
>0,1 48%
<0,1 46%
NOUVEAU
NOUVEAU
4 sept. 2026
<0,1
46%
0,1
50%
>0,1
48%
0,1 50%
>0,1 48%
<0,1 46%
NOUVEAU
NOUVEAU
4 sept. 2026
<0,1
$0 Vol.
46%
0,1
$0 Vol.
50%
>0,1
$0 Vol.
48%
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Current CDC FluSurv-NET data show laboratory-confirmed influenza-associated hospitalization rates at 0.1 per 100,000 population for Week 33 (ending August 22, 2026), with national activity remaining very low.** Influenza positive tests stood at just 0.8% in clinical laboratories, influenza-like illness visits at 1.1%, and emergency department diagnoses of flu at 0.1%. These figures align with typical late-summer patterns after the 2025-26 season peak (moderate severity, driven largely by A(H3N2) strains) concluded in spring.
Week 34 rates (ending around August 29) are expected to stay near this baseline given stable low transmission, co-circulation of other respiratory viruses like rhinovirus, and no signs of early 2026-27 season onset. Preliminary FluSurv-NET and NHSN figures carry reporting lags and minor revisions that can shift the exact observed rate by small increments, creating genuine uncertainty around the precise 0.1 threshold. Market-implied odds reflect this tight balance between confirmed low-level persistence and the potential for negligible fluctuations driven by surveillance variability or isolated clusters. Updated FluView and RESP-NET releases in coming days will clarify the final observed value.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Marché ouvert : Aug 28, 2026, 11:04 AM ET
Volume
$0Date de fin
4 sept. 2026Marché ouvert
Aug 28, 2026, 11:04 AM ETRésolveur
0x69c47De9D...This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Current CDC FluSurv-NET data show laboratory-confirmed influenza-associated hospitalization rates at 0.1 per 100,000 population for Week 33 (ending August 22, 2026), with national activity remaining very low.** Influenza positive tests stood at just 0.8% in clinical laboratories, influenza-like illness visits at 1.1%, and emergency department diagnoses of flu at 0.1%. These figures align with typical late-summer patterns after the 2025-26 season peak (moderate severity, driven largely by A(H3N2) strains) concluded in spring.
Week 34 rates (ending around August 29) are expected to stay near this baseline given stable low transmission, co-circulation of other respiratory viruses like rhinovirus, and no signs of early 2026-27 season onset. Preliminary FluSurv-NET and NHSN figures carry reporting lags and minor revisions that can shift the exact observed rate by small increments, creating genuine uncertainty around the precise 0.1 threshold. Market-implied odds reflect this tight balance between confirmed low-level persistence and the potential for negligible fluctuations driven by surveillance variability or isolated clusters. Updated FluView and RESP-NET releases in coming days will clarify the final observed value.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$0Date de fin
4 sept. 2026Marché ouvert
Aug 28, 2026, 11:04 AM ETRésolveur
0x69c47De9D...**Current CDC FluSurv-NET data show laboratory-confirmed influenza-associated hospitalization rates at 0.1 per 100,000 population for Week 33 (ending August 22, 2026), with national activity remaining very low.** Influenza positive tests stood at just 0.8% in clinical laboratories, influenza-like illness visits at 1.1%, and emergency department diagnoses of flu at 0.1%. These figures align with typical late-summer patterns after the 2025-26 season peak (moderate severity, driven largely by A(H3N2) strains) concluded in spring. Week 34 rates (ending around August 29) are expected to stay near this baseline given stable low transmission, co-circulation of other respiratory viruses like rhinovirus, and no signs of early 2026-27 season onset. Preliminary FluSurv-NET and NHSN figures carry reporting lags and minor revisions that can shift the exact observed rate by small increments, creating genuine uncertainty around the precise 0.1 threshold. Market-implied odds reflect this tight balance between confirmed low-level persistence and the potential for negligible fluctuations driven by surveillance variability or isolated clusters. Updated FluView and RESP-NET releases in coming days will clarify the final observed value.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes